Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population.

Abstract

OBJECTIVE To examine the effectiveness of intramuscular (IM) midazolam versus intravenous (IV) lorazepam for the treatment of pediatric patients with status epilepticus (SE) in the prehospital care setting. METHODS This multicenter clinical trial randomized patients diagnosed with SE to receive either IM midazolam or IV lorazepam administered by… (More)
DOI: 10.1111/epi.12905

Topics

4 Figures and Tables

Cite this paper

@article{Welch2015IntramuscularMV, title={Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population.}, author={Robert D. Welch and K. Nicholas and Valerie L Durkalski-Mauldin and Daniel H. Lowenstein and Robin A Conwit and Prashant V. Mahajan and Christopher A Lewandowski and R Silbergleit}, journal={Epilepsia}, year={2015}, volume={56 2}, pages={254-62} }